1. Singapore Stocks

  2. •

    Distribution services

  3. •

    Electronics distributors
Accrelist Ltd.

Accrelist Ltd.

SSGX:QZG
0.11
SGD
+0.02
(+25.00%)
16.69MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.7
0.05
0.02
- -
8.53
0.61
0.5
0.54
0.14
0.06
0.04
0.04
0.05
- -
Basic EPS, GAAP
-0.21
0.01
-0.04
-0.03
-0.02
- -
-0.04
- -
-0.04
-0.02
-0.01
-0.01
- -
- -
Free Cash Flow per Basic Share
-0.19
-0.12
-0.01
0.04
0.3
-0.04
0.04
0.02
-0.01
- -
-0.03
-0.01
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.3
0.33
0.19
0.16
0.14
0.15
0.1
0.11
0.07
0.05
0.04
0.03
0.03
0.03
Tangible Book Value per Share
0.3
0.33
0.19
0.16
0.09
0.08
0.05
0.07
0.06
0.05
0.04
0.03
0.03
0.03
Basic Weighted Avg Shares
39
140
230
262
13
272
279
279
293
304
309
317
320
320
Sales/Revenue/Turnover
27
7
4
1
112
167
139
151
41
19
13
14
16
- -
Operating Margin (%)
11.56
-86.43
-48.85
-524.48
-5.01
-0.36
-5.37
-0.6
-11.99
-22.59
-42.39
-40.33
-22.84
- -
Depreciation Expense
- -
- -
- -
- -
2
3
4
4
5
4
3
3
3
- -
Net Income, GAAP
-8
2
-9
-8
- -
- -
-12
-1
-12
-5
-2
-5
-1
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
26.47
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-30.28
26.34
-240.75
-955.4
-0.28
0.09
-8.65
-0.38
-29.1
-28.23
-17.39
-33.23
-7.31
- -
Working Capital
34
27
34
25
24
17
9
20
15
22
16
2
-1
-1
LT Debt
- -
2
- -
3
4
2
5
3
3
3
1
2
1
1
Total Equity
39
47
49
41
49
56
42
43
33
26
21
14
12
12
Return on Invested Capital (%)
- -
- -
- -
- -
- -
0.56
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
-36.12
- -
- -
- -
- -
0.62
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
-36.62
4.04
-18.32
-18.41
-0.78
0.36
-34.64
-1.95
-45.92
-29.73
-16.15
-41.82
-13.07
- -

Capital Structure

SGD

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
ST Debt
2
2
2
LT Borrowings
- -
- -
- -
LT Finance Leases
2
2
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
320
320
321
Market Capitalization
12
10
17

Working Capital

SGD

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
Total Current Assets
10
9
7
Cash, Cash Equivalents & STI
7
5
4
Accounts Receivable, Net
- -
- -
- -
Inventories
1
1
1
Total Current Liabilities
8
8
9
Payables & Accruals
- -
- -
- -
ST Debt
2
2
2
Deferred Revenue
- -
- -
- -

Growth Rates

SGD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-11.99%
-22.74%
-17.14%
Free Cash Flow
-355.52%
-495.23%
-104.01%
Net Income, GAAP
-698.89%
370.84%
-75.48%
Sales/Revenue/Turnover
1,265.47%
-27.94%
11.48%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
13
2025
- -
- -
14
2026
- -
- -
16

Semi-annual Earnings Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.01
2025
- -
- -
-0.01
2026
- -
- -
- -

Semi-annual Dividends Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Sheng Ze Cheong
Full Time Employees
727
Sector
Distribution services
Industry
Electronics distributors
Address
Singapore Singapore
IPO Date
May 23, 2002
Website
accrelist.com.sg
Similar Companies
Optiemus Infracom Limited (NSE:OPTIEMUS)
Redington Limited (NSE:REDINGTON)
Avnet, Inc. (NASDAQ:AVT)
Rashi Peripherals Limited (NSE:RPTECH)
MM Group for Industry & International Trade (EGX:MTIE)
Arrow Electronics, Inc. (NYSE:ARW)
Business
Accrelist Ltd. is an investment holding company that provides medical aesthetic services, precision engineering and mould fabrication, and technology solutions. The company operates through three core business segments: Aesthetic Medical Services, Mechanical Business Unit, and Others. The Aesthetic Medical Services segment, operating primarily under the A.M Aesthetics brand, delivers medical aesthetic and cosmetic dermatology treatments, including laser skin rejuvenation, pigmentation and tattoo removal, acne and scar therapies, botulinum toxin and dermal filler injections, thread lifts, high-intensity focused ultrasound and radiofrequency skin tightening, and body contouring procedures; and develops and distributes clinical-grade dermatological skincare formulations under the A.M Skincare brand produced in collaboration with South Korean original design manufacturer partners. The Mechanical Business Unit, operated through its controlling interest in Jubilee Industries Holdings Ltd., provides precision plastic injection moulding services; and designs and fabricates high-precision plastic moulds used in consumer electronics, household appliances, automotive parts, and computer peripherals. The Others segment provides financial technology services, including merchant payment gateway integration, electronic wallet solutions, and artificial intelligence-driven facial recognition and identity verification platforms under the Accrelist A.I. brand. The company serves retail consumers and industrial clients across Singapore, Malaysia, and Mainland China. In recent corporate developments, Accrelist acquired a 51% equity interest in SJY Medical Pte. Ltd., adding four clinic locations across Novena Medical Centre, Nex Serangoon, Jurong Point, and SingPost Centre to its Singapore aesthetic medical network under the A.M Aesthetics banner. The company also expanded its regional footprint into Greater China by acquiring a 60% stake in Accrelist (Nanjing) Health Management Co. Ltd. to develop medical aesthetics and health management businesses. Accrelist is actively executing a strategic multi-year expansion program aimed at scaling its medical aesthetic network to 100 clinics across the Asia-Pacific region by 2029 through clinic acquisitions, technology-driven operational upgrades, and regional joint ventures. Accrelist Ltd. was incorporated in 1986 and is headquartered in Singapore.